Pharmacovigilance Agreement Sample Contracts

NORGINE LIMITED PHARMACOVIGILANCE Agreement Between
Pharmacovigilance Agreement • March 18th, 2020 • England

This Agreement is supplemental to the Asset Purchase and Licence Agreement between Norgine B.V. and CMS dated 30th December 2014 for the Product referenced in Appendix 1 (the “Asset Purchase and Licence Agreement”) and replaces the Prior Agreement hereafter defined.

AutoNDA by SimpleDocs
Pharmacovigilance Agreement for Elcitonin between AKP, AKPB, CMS HKCMS DMCC, and Shenzhen Kangzhe
Pharmacovigilance Agreement • February 21st, 2020
Module XIII – Pharmacovigilance (PV) Agreements
Pharmacovigilance Agreement • October 3rd, 2021
AMENDMENT NO. 1 TO PHARMACOVIGILANCE AGREEMENT
Pharmacovigilance Agreement • June 22nd, 2021

Norgine Limited, Norgine House, Widewater Place, Moorhall Road, Harefield, Uxbridge, Middlesex UB9 6NS (hereinafter referred to as “NORGINE”).

PHARMACOVIGILANCE AGREEMENT
Pharmacovigilance Agreement • August 5th, 2020

This Pharmacovigilance Agreement (this “Agreement”) is made and entered into as of [DATE] by and between Gelesis, Inc., a Delaware corporation with a business address of 501 Boylston Street, Suite 6102, Boston, MA 02116, USA (“Gelesis”) and CMS Bridging DMSS, a company organized under the laws of the United Arab Emirates with a business address of Unit No.: 205B, JBC1, Plot No.: JLT-PH1-G2A, Jumeirah Lakes Towers, Dubai, United Arab Emirates (“CMS”) Gelesis and CMS may be referred to herein collectively as the “Parties” and individually as a “Party.”

NORGINE LIMITED PHARMACOVIGILANCE Agreement Between
Pharmacovigilance Agreement • March 4th, 2015 • England

This Agreement is supplemental to the Asset Purchase and Licence AgreementXXXXX Agreement dated DD MMM YYYY30 December 2014 for the Product referenced in Appendix 1 (the “Asset Purchase and Licence AgreementXXXXX Agreement”).

Product Imdur (Isosorbide-5-mononitrate) Safety Agreement Last Updated NA Effective Date of Agreement DDMMYYY Version Number 1.0
Pharmacovigilance Agreement • June 16th, 2016

PHARMACOVIGILANCE AGREEMENT by and between ASTRAZENECA AB and Everest Future Limited for Imdur® product, brand and associated assets

PHARMACOVIGILANCE AGREEMENT Between Neurelis, Inc.
Pharmacovigilance Agreement • October 18th, 2020 • California

This Pharmacovigilance Agreement (“PVA”) is made and entered into with an effective date of DDMMYYYY between Neurelis, Inc. (“Neurelis”) and CMS (“CMS”) in order to comply with pharmacovigilance and regulatory responsibilities. Neurelis, Inc. and CMS may hereinafter be referred to individually as a “Party” or collectively as the “Parties”.

The views expressed in this presentation is my views and it
Pharmacovigilance Agreement • March 20th, 2023

A “binding contract” is any agreement that's legally enforceable. That means if you sign a binding contract and don't fulfill your end of the bargain, the other party can take you to court.

PRA Patient Safety and Pharmacovigilance Agreements
Pharmacovigilance Agreement • January 21st, 2020

Pharmacovigilance Agreements (PVAs) are agreements between two companies based on their Commercial Agreements that require an exchange of safety information between the two companies.

Pharmacovigilance Agreement for Elcitonin between AKP, AKPB, CMS Pharma, and Kangzhe
Pharmacovigilance Agreement • August 10th, 2018
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!